Oxymorphone hydrochloride | Radio Compass News | PharmaCompass.com

Grow Your Pharma Business Digitally

X

Market Place

Sourcing support

Sourcing Support

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

All News Oxymorphone Hydrochloride

U.S. subpoenas Endo for information on opioid painkillers

11 Jan 2018 //

REUTERS

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc

23 Jun 2017 //

PR NEWSWIRE

US FDA requests Endo Pharma remove Opana ER for risks related to abuse

12 Jun 2017 //

BIOSPECTRUM

FDA Asks Endo Pharma to Stop Selling Opana ER Amid Opioid Crisis

10 Jun 2017 //

BIOSPACE

Endo Statement On FDA Advisory Committees` Vote Related To OPANA® ER

14 Mar 2017 //

PR NEWSWIRE

FDA Panel To Re-Examine Opana ER

11 Mar 2017 //

SEEKING ALPHA

Endo Announces Agreement to Resolve FTC Investigation and Litigation

23 Jan 2017 //

PR NEWSWIRE

Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse

25 Aug 2016 //

IN PHARMATECHNOLOGIST

Endo withdraws abuse-deterrent labelling for Opana ER

15 Aug 2016 //

PHARMATIMES

Aurolife`s Generic Oxymorphone Hydrochloride approved in US for the relief of moderate to severe acute pain

26 Apr 2016 //

FDA

Cash is not king: FTC sues drug maker over pay-to-delay deal

01 Apr 2016 //

STAT

Depomed Acquires U.S. Rights, First-in-Class Pain Product from Grunenthal

17 Nov 2015 //

PR NEWSWIRE

Endo`s Opana ER (Oxymorphone Hcl) Receives Supplemental Approval in US For Pain

24 Jun 2015 //

FDA

Abandoned Painkiller Makes a Comeback

10 May 2015 //

MEDPAGE TODAY

Sun`s Generic Oxymorphone Hcl Approved in USA For Moderate to Severe Pain

30 Apr 2015 //

FDA